Alligator Bioscience AB (publ)

OM:ATORX Stock Report

Market Cap: SEK 404.8m

Alligator Bioscience Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Søren Bregenholt

Chief executive officer

SEK 5.2m

Total compensation

CEO salary percentage68.9%
CEO tenure3.4yrs
CEO ownershipn/a
Management average tenure2.8yrs
Board average tenure3yrs

Recent management updates

Recent updates

Will Alligator Bioscience (STO:ATORX) Spend Its Cash Wisely?

Dec 01
Will Alligator Bioscience (STO:ATORX) Spend Its Cash Wisely?

We're Keeping An Eye On Alligator Bioscience's (STO:ATORX) Cash Burn Rate

Dec 21
We're Keeping An Eye On Alligator Bioscience's (STO:ATORX) Cash Burn Rate

Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

Jul 30
Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

Jan 06
Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

Here's Why We're Watching Alligator Bioscience's (STO:ATORX) Cash Burn Situation

Aug 18
Here's Why We're Watching Alligator Bioscience's (STO:ATORX) Cash Burn Situation

CEO Compensation Analysis

How has Søren Bregenholt's remuneration changed compared to Alligator Bioscience's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 248m

Jun 30 2024n/an/a

-SEK 234m

Mar 31 2024n/an/a

-SEK 249m

Dec 31 2023SEK 5mSEK 4m

-SEK 249m

Sep 30 2023n/an/a

-SEK 232m

Jun 30 2023n/an/a

-SEK 231m

Mar 31 2023n/an/a

-SEK 213m

Dec 31 2022SEK 4mSEK 3m

-SEK 193m

Sep 30 2022n/an/a

-SEK 177m

Jun 30 2022n/an/a

-SEK 163m

Mar 31 2022n/an/a

-SEK 152m

Dec 31 2021SEK 4mSEK 2m

-SEK 142m

Compensation vs Market: Søren's total compensation ($USD473.03K) is above average for companies of similar size in the Swedish market ($USD236.30K).

Compensation vs Earnings: Søren's compensation has increased whilst the company is unprofitable.

CEO

Søren Bregenholt (53 yo)

3.4yrs

Tenure

SEK 5,201,000

Compensation

Mr. Søren Bregenholt, Ph D serves as the Chief Executive Officer at Alligator Bioscience AB (publ) since June 01, 2021. He served as the Chief Operating Officer of Symphogen A/S.Mr. Bregenholt served as S...

Leadership Team

NamePositionTenureCompensationOwnership
Søren Bregenholt
Chief Executive Officer3.4yrsSEK 5.20mno data
Johan Gileus
Chief Financial Officerless than a yearno datano data
Laura von Schantz
Chief Technology Officer2.8yrsno data0.00035%
SEK 1.4k
Peter Ellmark
Chief Scientific Officer3.8yrsno datano data
Greta Eklund
Investor Relations & Communications Managerno datano datano data
Sumeet Ambarkhane
Chief Medical Officer2.8yrsno datano data

2.8yrs

Average Tenure

53yo

Average Age

Experienced Management: ATORX's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Staffan Encrantz
Independent Director2.5yrsSEK 300.00kno data
Anders Ekblom
Independent Chairman of the Board7.5yrsSEK 700.00k0.015%
SEK 62.2k
Hans-Peter Ostler
Independent Vice Chairman of the Board3.4yrsSEK 525.00kno data
Denise Goode
Independent Director2.5yrsSEK 350.00kno data
Eva Saers
Independent Director3.4yrsSEK 350.00kno data
Karin Nordbladh
Employee Representative Director1.8yrsno datano data

3.0yrs

Average Tenure

66yo

Average Age

Experienced Board: ATORX's board of directors are not considered experienced ( 3 years average tenure), which suggests a new board.